| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
With personalized treatments and guidance from medical and athletic professionals, you can achieve your health and fitness goals at Altus.
Green River Regional Mental Health Mental Retardation Board Inc is a Owensboro, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MSC Group is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aspenbio Pharma Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Castle Rock, CO. To find more information about Aspenbio Pharma Inc, please visit www.aspenbiopharma.com